Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Polystyrene nanoparticles trigger aberrant condensation of TDP-43 and amyotrophic lateral sclerosis-like symptoms

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the dysfunction and progressive death of cerebral and spinal motor neurons. Preliminary epidemiological research has hinted at a relationship between environmental risks and the escalation of ALS, but the underlying reasons remain mostly mysterious. Here we show that nanosize polystyrene plastics (PS) induce ALS-like symptoms and illustrate the related molecular mechanism. When exposed to PS, cells endure internal oxidative stress, which leads to the aggregation of TAR DNA-binding protein 43 kDa (TDP-43), triggering ALS-like characteristics. In addition, the oxidized heat shock protein 70 fails to escort TDP-43 back to the nucleus. The cytoplasmic accumulation of TDP-43 facilitates the formation of a complex between PS and TDP-43, enhancing the condensation and solidification of TDP-43. These findings are corroborated through in silico and in vivo assays. Altogether, our work illustrates a unique toxicological mechanism induced by nanoparticles and provides insights into the connection between environmental pollution and neurodegenerative disorders.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: PS regulates the dynamic assembly and liquid-to-solid phase transition of nuclear TDP-43 condensates.
Fig. 2: PS accelerates solid-like nuclear TDP-43 condensates formation by oxidizing chaperone Hsp70.
Fig. 3: TDP-43 cytoplasmic translocation and the formation of PS@TDP-43 complexes.
Fig. 4: PS@TDP-43 complexes promote cytoplasmic TDP-43 condensation and solidification.
Fig. 5: Molecular docking analysis of the effect of PS adsorption on the binding affinity of two TDP-43 molecules.
Fig. 6: PS intranasal exposure causes ALS-like neurodegeneration and liquid-droplet-like TDP-43 formation in mice.

Similar content being viewed by others

Data availability

The source data underlying the main text figures (Figs. 14 and 6 and Extended Data Figs. 14) and the supplementary figures (Supplementary Figs. 1, 4, 6, 7, 8, 10, 11, 14, 15) and videos (Supplementary Videos 18) are provided as source data files or deposited in Gene Expression Omnibus (RNA-seq) under accession number GSE264018. The description data for the TDP-43 structure were acquired from the AlphaFold Protein Structure Database (AlphaFoldDB) under the accession code AF-Q13148-F1. TDP-43 protein disorder region scores from Predictor of Natural Disorder Regions (PONDR; an online tool, http://www.pondr.com/).

References

  1. Brahney, J., Hallerud, M., Heim, E., Hahnenberger, M. & Sukumaran, S. Plastic rain in protected areas of the United States. Science 368, 1257–1260 (2020).

    Article  CAS  PubMed  Google Scholar 

  2. Morales, A. C. et al. Atmospheric emission of nanoplastics from sewer pipe repairs. Nat. Nanotechnol. 17, 1171–1177 (2022).

    Article  CAS  PubMed  Google Scholar 

  3. Pauly, J. L. et al. Inhaled cellulosic and plastic fibers found in human lung tissue. Cancer Epidemiol. Biomarkers Prev. 7, 419–428 (1998).

    CAS  PubMed  Google Scholar 

  4. Prust, M., Meijer, J. & Westerink, R. H. S. The plastic brain: neurotoxicity of micro- and nanoplastics. Part. Fibre Toxicol. 17, 24 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Liu, X. et al. Bioeffects of inhaled nanoplastics on neurons and alteration of animal behaviors through deposition in the brain. Nano Lett. 22, 1091–1099 (2022).

    Article  CAS  PubMed  Google Scholar 

  6. Chen, H. et al. Living near major roads and the incidence of dementia, Parkinson’s disease, and multiple sclerosis: a population-based cohort study. Lancet 389, 718–726 (2017).

    Article  PubMed  Google Scholar 

  7. Yu, Z. et al. Long-term exposure to ultrafine particles and particulate matter constituents and the risk of amyotrophic lateral sclerosis. Environ. Health Perspect. 129, 97702 (2021).

    Article  CAS  PubMed  Google Scholar 

  8. Taylor, J. P., Brown, R. H. & Cleveland, D. W. Decoding ALS: from genes to mechanism. Nature 539, 197–206 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kiernan, M. C. et al. Amyotrophic lateral sclerosis. Lancet 377, 942–955 (2011).

    Article  CAS  PubMed  Google Scholar 

  10. Ling, S. C., Polymenidou, M. & Cleveland, D. W. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416–438 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Sreedharan, J. et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668–1672 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130–133 (2006).

    Article  CAS  PubMed  Google Scholar 

  13. Baughn, M. W. et al. Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies. Science 379, 1140–1149 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Jo, M. et al. The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Exp. Mol. Med. 52, 1652–1662 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Banani, S. F., Lee, H. O., Hyman, A. A. & Rosen, M. K. Biomolecular condensates: organizers of cellular biochemistry. Nat. Rev. Mol. Cell Biol. 18, 285–298 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. McGurk, L. et al. Poly(ADP-ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization. Mol. Cell 71, 703–717.e709 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lu, S. et al. Heat-shock chaperone HSPB1 regulates cytoplasmic TDP-43 phase separation and liquid-to-gel transition. Nat. Cell Biol. 24, 1378–1393 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Wang, C. et al. Stress induces dynamic, cytotoxicity-antagonizing TDP-43 nuclear bodies via paraspeckle LncRNA NEAT1-mediated liquid-liquid phase separation. Mol Cell 79, 443–458.e447 (2020).

    Article  CAS  PubMed  Google Scholar 

  19. Liu, X. et al. Serum. apolipoprotein A-I depletion is causative to silica nanoparticles-induced cardiovascular damage. Proc. Natl Acad. Sci. USA 118, e2108131118 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Kik, K., Bukowska, B. & Sicinska, P. Polystyrene nanoparticles: sources, occurrence in the environment, distribution in tissues, accumulation and toxicity to various organisms. Environ. Pollut. 262, 114297 (2020).

    Article  CAS  PubMed  Google Scholar 

  21. Zhao, Y. G. & Zhang, H. Phase separation in membrane biology: the interplay between membrane-bound organelles and membraneless condensates. Dev. Cell 55, 30–44 (2020).

    Article  CAS  PubMed  Google Scholar 

  22. Zuo, X. et al. TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS. Nat. Struct. Mol. Biol. 28, 132–142 (2021).

    Article  CAS  PubMed  Google Scholar 

  23. Wolozin, B. & Ivanov, P. Stress granules and neurodegeneration. Nat. Rev. Neurosci. 20, 649–666 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Gu, J. et al. Hsp70 chaperones TDP-43 in dynamic, liquid-like phase and prevents it from amyloid aggregation. Cell Res. 31, 1024–1027 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Chen-Plotkin, A. S., Lee, V. M. & Trojanowski, J. Q. TAR DNA-binding protein 43 in neurodegenerative disease. Nat. Rev. Neurol. 6, 211–220 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gasset-Rosa, F. et al. Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron 102, 339–357.e337 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Neumann, M. et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 117, 137–149 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Laferrière, F. et al. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nat. Neurosci. 22, 65–77 (2019).

    Article  PubMed  Google Scholar 

  29. Frottin, F. et al. The nucleolus functions as a phase-separated protein quality control compartment. Science 365, 342–347 (2019).

    Article  CAS  PubMed  Google Scholar 

  30. Eisele, Y. S. et al. Targeting protein aggregation for the treatment of degenerative diseases. Nat. Rev. Drug Discov. 14, 759–780 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Conicella, A. E. et al. TDP-43 α-helical structure tunes liquid–liquid phase separation and function. Proc. Natl Acad. Sci. USA 117, 5883–5894 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Yu, H. et al. HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells. Science 371, eabb4309 (2021).

    Article  CAS  PubMed  Google Scholar 

  33. Callahan, M. K., Chaillot, D., Jacquin, C., Clark, P. R. & Ménoret, A. Differential acquisition of antigenic peptides by Hsp70 and Hsc70 under oxidative conditions. J. Biol. Chem. 277, 33604–33609 (2002).

    Article  CAS  PubMed  Google Scholar 

  34. Suk, T. R. & Rousseaux, M. W. C. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol. Neurodegener. 15, 45 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Gottschald, O. R. et al. TIAR and TIA-1 mRNA-binding proteins co-aggregate under conditions of rapid oxygen decline and extreme hypoxia and suppress the HIF-1α pathway. J. Mol. Cell. Biol. 2, 345–356 (2010).

    Article  CAS  PubMed  Google Scholar 

  36. Boeynaems, S. & Gitler, A. D. Pour some sugar on TDP(-43). Mol. Cell 71, 649–651 (2018).

    Article  CAS  PubMed  Google Scholar 

  37. Streit, L. et al. Stress induced TDP-43 mobility loss independent of stress granules. Nat. Commun. 13, 5480 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Duan, Y. et al. PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins. Cell Res. 29, 233–247 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Chhangani, D., Martin-Pena, A. & Rincon-Limas, D. E. Molecular, functional, and pathological aspects of TDP-43 fragmentation. iScience 24, 102459 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Linse, S. et al. Nucleation of protein fibrillation by nanoparticles. Proc. Natl Acad. Sci. USA 104, 8691–8696 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Sassani, M. et al. Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis. Brain 143, 3603–3618 (2020).

    Article  PubMed  Google Scholar 

  42. Colasuonno, F., Price, R. & Moreno, S. Upper and lower motor neurons and the skeletal muscle: implication for amyotrophic lateral sclerosis (ALS). Adv. Anat. Embryol. Cell Biol. 236, 111–129 (2023).

    Article  PubMed  Google Scholar 

  43. Mead, R. J., Shan, N., Reiser, H. J., Marshall, F. & Shaw, P. J. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat. Rev. Drug Discov. 22, 185–212 (2023).

    Article  CAS  PubMed  Google Scholar 

  44. Kurashige, T. et al. TDP-43 accumulation within intramuscular nerve bundles of patients with amyotrophic lateral sclerosis. JAMA Neurol. 79, 693–701 (2022).

    Article  PubMed  Google Scholar 

  45. Grunwald, M. S. et al. The oxidation of HSP70 is associated with functional impairment and lack of stimulatory capacity. Cell Stress Chaperones 19, 913–925 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Sun, H. et al. Oral exposure of polystyrene microplastics and doxycycline affects mice neurological function via gut microbiota disruption: the orchestrating role of fecal microbiota transplantation. J. Hazard. Mater. 467, 133714 (2024).

    Article  CAS  PubMed  Google Scholar 

  47. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Feldman, A. T. & Wolfe, D. Tissue processing and hematoxylin and eosin staining. Methods Mol. Biol. 1180, 31–43 (2014).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work is supported by the National Key R&D Program of China (2023YFC3708303 to Y.S.), Strategic Priority Research Program of the Chinese Academy of Sciences (XDB0750300 to Y.S.) and National Natural Science Foundation of China (22176206 to Y.S. and 22174116 to E.S.).

Author information

Authors and Affiliations

Authors

Contributions

H.S. and Y.S. conceived the study. H.S., B.Y., Q.L. and X.Z. performed assays and contributed to data interpretation. E.S. and Y.S. supervised the experiments. H.S., C.L. and Y.S. wrote the paper. E.S., Y.S. and G.J. provided reagents and oversaw the research. All authors had input on the content of the paper and approved the final version of the paper.

Corresponding author

Correspondence to Yang Song.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Nanotechnology thanks Pilong Li and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Extended Data Fig. 1 PS exposure induces transgenic/endogenous nuclear TDP-43 granules formation in HeLa cells.

a, Representative images and the fluorescence intensity profile along the indicated white line of HeLa cells forming EGFPTDP-43 granules at 6 h after the indicated concentrations of PS treatment. b, The percentage of cells forming EGFPTDP-43 granules in (a). Data are expressed as means ± SD. n = 3, 50 cells per experiment, as determined by one-way ANOVA with Tukey’s multiple comparison tests (p = 0.0167 and 0.0012 for PS of 50 and 100 µg/mL vs. 0 µg/mL, respectively; ns, p > 0.05). c, Representative images and d, fluorescence intensity profile along the indicated white line of HeLa cells forming endogenous TDP-43 granules (arrows) in response to indicated PS exposure concentrations after 6 h. n = 3 independent experiments per group.

Source data

Extended Data Fig. 2 PS exposure-induced cellular stress and compromised organelles in HeLa cells.

a, Representative images of NAC inhibit PS-triggered nuclear EGFPTDP-43 condensates formation. NAC, 2 mM, PS, 100 µg/mL, 6 h. b, The relative ROS levels (using the DCF-DA probe) were detected by flow cytometry. Data are expressed as means ± SD, n = 3, as determined by one-way ANOVA with Tukey’s multiple comparison tests (Ctrl vs. NAC, p = 0.9742; Ctrl vs. PS, p < 0.0001; Ctrl vs. PS + NAC, p = 0.1539; PS vs. PS + NAC, p < 0.0001). c, Quantification of nuclear EGFPTDP-43 condensates number per cell in (b) (n = 10 cells). Data are displayed as the median +/− the interquartile range, n = 3, as determined by one-way ANOVA with Tukey’s multiple comparison tests (p < 0.0001; ns, p > 0.05; Ctrl vs. PS+NAC, p = 0.0081). d, Representative images of p-eIF2α expression levels in HeLa cells. GAPDH was used as internal control. e, Quantification of p-eIF2α expression in (d). Data are expressed as means ± SD, n = 3, as determined by one-way ANOVA with Tukey’s multiple comparison tests. (Ctrl vs. PS 6 h, p = 0.0404; Ctrl vs. PS 12 h, p = 0.0092; Ctrl vs. PS 24 h, p = 0.0300; ns, p > 0.05). f, Representative images of JC-1, AO and Magic red staining in HeLa cells after PS exposure. Red JC-1 aggregates indicate high MMP, and the green JC-1 monomers indicate low MMP; Lysosomal membrane permeability was detected by AO. AO in the intact lysosomes (red), cytoplasm (green); Cathepsin B release was detected by Magic Red staining. Magic Red (red), DAPI (blue). n = 3. g, Flow cytometry was used to quantify PS-induced MMP loss (JC-1), cell membrane damage (PI), lysosomal membrane permeability (AO) and Cathepsin B release (Magic Red). Data are expressed as means ± SD, n = 3, as determined by one-way ANOVA with Tukey’s multiple comparison tests (For JC-1 test, Ctrl vs. 6, 12, 24 h, p = 0.0075, p = 0.0002, p < 0.0001, respectively; For PI test, Ctrl vs. 6, 12, 24 h, p = 0.0371, p < 0.0001, p < 0.0001, respectively; For AO test, Ctrl vs. 6, 12, 24 h, p = 0.2378, p < 0.0001, p < 0.0001, respectively; For Cathepsin B test, Ctrl vs. 6, 12, 24 h, p = 0.0003, p < 0.0001, p < 0.0001, respectively).

Source data

Extended Data Fig. 3 Solid-like nuclear TDP-43 condensates formation is required for PS exposure-induced TDP-43 pathology.

a, EGFPTDP-43 transfected HeLa cells exposed to PS (100 µg/mL) followed by immunostaining with anti-pTDP-43 (Ser409/410). Nuclei are marked by dashed circles. b, The percentage of cells expressing pTDP-43 in (a). Data are expressed as means ± SD (n = 3, 25 cells per experiment), as determined by one-way ANOVA with Tukey’s multiple comparison tests (Ctrl vs. PS 12 h, p = 0.0121; Ctrl vs. PS 24 h, p = 0.0010; PS 6 h vs. PS 12 h, p = 0.0314; PS 6 h vs. PS 24 h, p = 0.0021; ns, p > 0.05). c, Representative images of phosphorylation levels of nuclear TDP-43 (N-pTDP-43). Lamin B was used as an internal control. d, Quantification of nuclear TDP-43 phosphorylation. Data are expressed as means ± SD (n = 3), as determined by one-sided one-way ANOVA with Tukey’s multiple comparison tests (Ctrl vs. PS 6 h, p = 0.8011; Ctrl vs. PS 12 h, p = 0.0018; Ctrl vs. PS 24 h, p < 0.0001; PS 6 h vs. PS 12 h, p = 0.0051; PS 6 h vs. PS 24 h, p < 0.0001; PS 12 h vs. PS 24 h, p < 0.0001). e, AmyT staining. Nuclei are marked by dashed circles. f, The percentage of cells showing AmyT in (e). Data are expressed as means ± SD (n = 3, 25 cells per experiment), as determined by one-sided one-way ANOVA with Tukey’s multiple comparison tests (Ctrl vs. PS 24 h, p = 0.0024; PS 6 h vs. PS 24 h, p = 0.0040; PS 12 h vs. PS 24 h, p = 0.0117; ns, p > 0.05). g, Representative images of HeLa cells expressing WT or A326P TDP-43-HA in the presence of PS (100 µg/mL). h, CCK8 assay showed the effect of PS-triggered TDP-43 LLPS on the viability of HeLa cells. Data are expressed as means ± SD (n = 3), as determined by two-way ANOVA with Bonferroni’s multiple comparison tests (PS 6 h, WT vs. A326P, p = 0.0153; PS 12 h, WT vs. A326P, p = 0.0069; PS 24 h, WT vs. A326P, p = 0.0465; ns, p > 0.05).

Source data

Extended Data Fig. 4 PS exposure triggers TDP-43 cytoplasmic translocation.

a, Three-dimensional reconstruction images of TDP-43 recruitment to SGs in Fig. 3a. b, Representative images of TDP-43 expression levels in the nucleus (N-TDP-43) and the cytoplasm (Cyto-TDP-43) in HeLa cells. Lamin B and GAPDH were used as internal controls for the nucleus and cytoplasm, respectively. c, Quantification of TDP-43 expression in the nucleus. Data are expressed as means ± SD, n = 3, as determined by one-way ANOVA with Tukey’s multiple comparison tests (Ctrl vs. PS 12 h, p = 0.0444; Ctrl vs. PS 24 h, p = 0.0464; ns, p > 0.05). d, Quantification of TDP-43 expression in the cytoplasm. Data are expressed as means ± SD, n = 3, as determined by one-way ANOVA with Tukey’s multiple comparison tests (Ctrl vs. PS 12 h, p = 0.0189; Ctrl vs. PS 24 h, p = 0.0240; ns, p > 0.05).

Source data

Extended Data Fig. 5 PS exacerbates the pathological tendency of TDP-43.

Schematic illustration of the role of PS exposure in the aberrant phase separation and pathology of TDP-43.

Supplementary information

Supplementary Information

Supplementary Figs. 1–16 and Tables 1 and 2.

Reporting Summary

Supplementary Video 1

TDP-43 condensates morphology, related to Supplementary Fig. 3.

Supplementary Video 2

TDP-43 condensates morphology, related to Supplementary Fig. 3.

Supplementary Video 3

TDP-43 condensates fusion event, related to Fig. 1b.

Supplementary Video 4

TDP-43 condensates FRAP analysis, related to Fig. 1c.

Supplementary Video 5

TDP-43 recruitment to SGs, related to Fig. 3a. TIAR, SGs marker (red), EGFPTDP-43 (green), DAPI (blue).

Supplementary Video 6

TDP-43 recruitment to SGs, related to Fig. 3a. TIAR, SGs marker (red), EGFPTDP-43 (green), DAPI (blue).

Supplementary Video 7

TDP-43 recruitment to SGs, related to Fig. 3a. TIAR, SGs marker (red), EGFPTDP-43 (green), DAPI (blue).

Supplementary Video 8

Partial RFPS and cytoplasmic TDP-43 condensates co-localize in the cytoplasm, related to Fig. 3f. EGFPTDP-43 (green), RFPS (red).

Supplementary Data 1

Statistical source data and unprocessed gels for supplementary figures.

Source data

Source Data Fig. 1

Statistical source data for Fig. 1.

Source Data Fig. 2

Statistical source data and unprocessed gels for Fig. 2.

Source Data Fig. 3

Statistical source data for Fig. 3.

Source Data Fig. 4

Statistical source data for Fig. 4.

Source Data Fig. 6

Statistical source data for Fig. 6.

Source Data Extended Data Fig. 1

Statistical source data for Extended Data Fig. 1.

Source Data Extended Data Fig. 2

Statistical source data and unprocessed gels for Extended Data Fig. 2.

Source Data Extended Data Fig. 3

Statistical source data and unprocessed gels for Extended Data Fig. 3.

Source Data Extended Data Fig. 4

Statistical source data and unprocessed gels for Extended Data Fig. 4.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, H., Yang, B., Li, Q. et al. Polystyrene nanoparticles trigger aberrant condensation of TDP-43 and amyotrophic lateral sclerosis-like symptoms. Nat. Nanotechnol. (2024). https://doi.org/10.1038/s41565-024-01683-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41565-024-01683-5

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing